iRadimed Q3'26 Earnings Preview: EPS Estimate at 0.55
iRadimed is scheduled to report Q3'26 results on October 30 before the market opens. Revenue is estimated at 23.47 million USD, with EPS expected at 0.55 USD.
IRMD (iRadimed Corporation) is set to announce its Q3'26 results on October 30, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (1:30 PM UTC).For Q3'26, revenue estimate is 23.47 million USD with EPS (earnings per share) anticipated at 0.55 USD. Learn more details a…